Neuroscience
Bipolar Disorder
100%
Duloxetine
45%
Major Depressive Disorder
39%
Default Mode Network
36%
Functional Connectivity
33%
Neurotransmitter
29%
Antidepressant
26%
Dementia Praecox
20%
Bipolar Depression
20%
Cognitive Disorders
18%
Diffusion Tensor Imaging
15%
Serotonin
15%
Thalamus
15%
Hamilton Rating Scale for Depression
14%
Motor Cortex
14%
Substantia nigra
13%
Behavior (Neuroscience)
13%
Bipolar II Disorder
13%
Raphe Nucleus
11%
Bipolar Mania
11%
Multiple Sclerosis
11%
Agomelatine
11%
Functional Magnetic Resonance Imaging
10%
Basal Ganglia
8%
Hyperactivity
7%
Norepinephrine
7%
Hypomania
7%
δ -Opioid Receptor
6%
Prefrontal Cortex
6%
Cingulum
6%
Bipolar I Disorder
6%
Vascular Endothelial Growth Factor
5%
Electroretinography
5%
Antidepressant
5%
Anterior Cingulate Cortex
5%
Hippocampus
5%
Interleukin 6
5%
Obsessive-Compulsive Disorder
5%
Brain Function
5%
Zonisamide
5%
Type I of Bipolar Disorder
5%
Primary Progressive Multiple Sclerosis
5%
Nerve Growth Factor
5%
Receptor Gene
5%
Beta-Endorphin
5%
Brain-Derived Neurotrophic Factor
5%
Gene Expression
5%
μ-Opioid Receptor
5%
Atypical Depression
5%
Placebo
5%
Medicine and Dentistry
Bipolar Disorder
15%
Default Mode Network
9%
Antidepressant
8%
Salience Network
7%
Sensation Seeking
5%
Agomelatine
5%
Functional Connectivity
5%
Electroencephalogram
5%
Cingulate Cortex
5%
Antidepressant Activity
5%
κ-Opioid Receptor
5%
Immunomodulation
5%
Bipolar II Disorder
5%
Th1 Th2 Balance
5%
Patient Compliance
5%
Noradrenalin
5%
Drug Therapy
5%
Atypical Depression
5%
Serotonin
5%
Placebo
5%
Duloxetine
5%
Bupropion
5%
Pharmacology, Toxicology and Pharmaceutical Science
Duloxetine
11%
Agomelatine
11%
Bipolar II Disorder
11%
Antidepressant
7%
Bipolar Disorder
6%
Serotonin Receptor
6%
Tolerability
6%
Atypical Depression
5%
Psychopharmacology
5%
Selective Serotonin Reuptake Inhibitor
5%
Placebo
5%
Opiate Receptor
5%
Bupropion
5%
Zonisamide
5%
Nausea
5%
Tinnitus
5%
Sodium Valproate
5%
